Event Details
Twelfth SDDA Event
Event Process:
Topic | Speaker |
---|---|
Opening | President of Sino Drug Discovery Association |
CAR-T and Immunotherapy for Cancer Treatment | Richard Wang, Ph.D. Chief Operation Officer, Cellular Biomedicine Group (NASDAQ: CBMG) |
HTRF-A Powerful Assay Platform for Immune Checkpoint Inhibitors – PD1/PD-L1 Blocker | Wenjun LI, Ph.D. Technical Sales, Cisbio Bioassays |
Previous:
Thirteenth SDDA Event
Next:
Eleventh SDDA Event